BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25576592)

  • 1. Trimming of two major type 1 diabetes driving antigens, GAD65 and IA-2, allows for successful expression in Lactococcus lactis.
    Robert S; Van Huynegem K; Gysemans C; Mathieu C; Rottiers P; Steidler L
    Benef Microbes; 2015; 6(4):591-601. PubMed ID: 25576592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of Lactococcus lactis-expressing heat shock protein 65 and tandemly repeated IA2P2 prevents type 1 diabetes in NOD mice.
    Liu KF; Liu XR; Li GL; Lu SP; Jin L; Wu J
    Immunol Lett; 2016 Jun; 174():28-36. PubMed ID: 27085380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
    Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
    Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice.
    Robert S; Gysemans C; Takiishi T; Korf H; Spagnuolo I; Sebastiani G; Van Huynegem K; Steidler L; Caluwaerts S; Demetter P; Wasserfall CH; Atkinson MA; Dotta F; Rottiers P; Van Belle TL; Mathieu C
    Diabetes; 2014 Aug; 63(8):2876-87. PubMed ID: 24677716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization.
    Li HS; Piao DC; Jiang T; Bok JD; Cho CS; Lee YS; Kang SK; Choi YJ
    Vaccine; 2015 Apr; 33(16):1959-67. PubMed ID: 25738814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA-2, IA-2β, and GAD65.
    Abuhatzira L; Xu H; Tahhan G; Boulougoura A; Schäffer AA; Notkins AL
    FASEB J; 2015 Oct; 29(10):4374-83. PubMed ID: 26148972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
    Davison LJ; Weenink SM; Christie MR; Herrtage ME; Catchpole B
    Vet Immunol Immunopathol; 2008 Nov; 126(1-2):83-90. PubMed ID: 18706702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization.
    Frossard CP; Steidler L; Eigenmann PA
    J Allergy Clin Immunol; 2007 Apr; 119(4):952-9. PubMed ID: 17316776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice.
    Takiishi T; Korf H; Van Belle TL; Robert S; Grieco FA; Caluwaerts S; Galleri L; Spagnuolo I; Steidler L; Van Huynegem K; Demetter P; Wasserfall C; Atkinson MA; Dotta F; Rottiers P; Gysemans C; Mathieu C
    J Clin Invest; 2012 May; 122(5):1717-25. PubMed ID: 22484814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant
    Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
    J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of an immunoreactive single-chain variable fragment antibody against mouse interleukin 6 by Lactococcus lactis.
    Shigemori S; Ihara M; Sato T; Yamamoto Y; Nigar S; Ogita T; Shimosato T
    Appl Microbiol Biotechnol; 2017 Jan; 101(1):341-349. PubMed ID: 27722916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta.
    Li Q; Borovitskaya AE; DeSilva MG; Wasserfall C; Maclaren NK; Notkins AL; Lan MS
    Proc Assoc Am Physicians; 1997 Jul; 109(4):429-39. PubMed ID: 9220540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation with human recombinant autoantigens.
    Lernmark A; Agardh CD
    Trends Immunol; 2005 Nov; 26(11):608-12. PubMed ID: 16153889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant invasive Lactococcus lactis can transfer DNA vaccines either directly to dendritic cells or across an epithelial cell monolayer.
    de Azevedo M; Meijerink M; Taverne N; Pereira VB; LeBlanc JG; Azevedo V; Miyoshi A; Langella P; Wells JM; Chatel JM
    Vaccine; 2015 Sep; 33(38):4807-12. PubMed ID: 26241952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.
    Martín R; Chain F; Miquel S; Natividad JM; Sokol H; Verdu EF; Langella P; Bermúdez-Humarán LG
    Hum Vaccin Immunother; 2014; 10(6):1611-21. PubMed ID: 24732667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Jing H; Yong L; Haiyan L; Yanjun M; Yun X; Yu Z; Taiming L; Rongyue C; Liang J; Jie W; Li Z; Jingjing L
    Vaccine; 2011 May; 29(24):4102-9. PubMed ID: 21497632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of biologically active human interleukin 22 (IL-22) by Lactococcus lactis.
    Loera-Arias MJ; Villatoro-Hernández J; Parga-Castillo MA; Salcido-Montenegro A; Barboza-Quintana O; Muñoz-Maldonado GE; Montes-de-Oca-Luna R; Saucedo-Cárdenas O
    Biotechnol Lett; 2014 Dec; 36(12):2489-94. PubMed ID: 25214209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M cell-targeting strategy enhances systemic and mucosal immune responses induced by oral administration of nuclease-producing L. lactis.
    Takahashi K; Yano A; Watanabe S; Langella P; Bermúdez-Humarán LG; Inoue N
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10703-10711. PubMed ID: 30310964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HtrA is essential for efficient secretion of recombinant proteins by Lactococcus lactis.
    Sriraman K; Jayaraman G
    Appl Environ Microbiol; 2008 Dec; 74(23):7442-6. PubMed ID: 18836019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerogenic dendritic cells induce antigen-specific hyporesponsiveness in insulin- and glutamic acid decarboxylase 65-autoreactive T lymphocytes from type 1 diabetic patients.
    Segovia-Gamboa N; Rodríguez-Arellano ME; Rangel-Cruz R; Sánchez-Díaz M; Ramírez-Reyes JC; Faradji R; González-Domínguez É; Sánchez-Torres C
    Clin Immunol; 2014 Sep; 154(1):72-83. PubMed ID: 24993292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.